Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer.
Carella
Angelo M
AM
Department Hematology-Oncology, Ospedale Casa Sollievo Della Sofferenza, Irccs San Giovanni Rotondo, Fg., Italy.
Beltrami
Germana
G
Lerma
Enrica
E
Cavaliere
Marina
M
Corsetti
Maria T
MT
D001943:Breast Neoplasms / Q000628:therapy*; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control; D019337:Hematologic Neoplasms / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D019172:Transplantation Conditioning / Q000379:methods*; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D014740:Vidarabine / Q000031:analogs & derivatives / Q000494:pharmacology
D014740:Vidarabine; C024352:fludarabine